Eye drug to hit market with price of $995 per injection

12/22/2004 | Reuters

Eyetech Pharmaceuticals set a price of $995 per injection for Macugen, a new drug to treat wet age-related macular degeneration, the leading cause of blindness in the elderly. The drug is to be injected about nine times a year, bringing the total cost to $9,000. Eyetech and its partner, Pfizer, plan to begin selling the drug early next year.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ